Obstacles to Combining Artificial Intelligence with Nanotechnology for Nucleic Acid Delivery

This chapter elucidates the dynamic relationship between artificial intelligence (AI) and nanotechnology, exploring their convergence, challenges, and transformative potential. As two frontier disciplines, AI and nanotechnology offer complementary capabilities that, when combined, promise groundbreaking advancements across various domains. However, realizing this potential is not without hurdles. Technical obstacles, such as scalability issues and algorithm–device compatibility, impede seamless integration. Ethical dilemmas, including privacy concerns and autonomous decision-making in nanorobotics, pose significant considerations. Moreover, navigating the regulatory landscape for AI-nanotechnology products presents additional complexities, necessitating harmonized regulations and robust safety protocols. Despite these challenges, strategic approaches can overcome barriers to integration. Interdisciplinary collaboration fosters innovative solutions, while research initiatives drive progress in AI-nanotechnology synergy. Effective policy advocacy ensures responsible development and deployment of AI-nanotechnology applications. Illustrative case studies highlight the transformative impact of AI-nanotechnology integration. From AI-driven drug delivery systems to smart materials and nanofabrication techniques, these examples showcase the diverse applications and potential benefits. Looking ahead, the convergence of AI and nanotechnology holds immense promise for revolutionizing industries such as healthcare, manufacturing, and beyond. In conclusion, the synergy between AI and nanotechnology represents a frontier of innovation with profound implications for society and industry. By addressing challenges through collaboration, innovation, and responsible governance, we can unlock the full potential of AI-nanotechnology integration, paving the way for a future of unprecedented technological advancement and societal benefit.